GT

Gaurav Tiwari

Active Director Director DIN 08896778
DIN 08896778 First appointment Sep 2020 Primary industry Chemicals
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Sep 2020
Shareholding value •••• Premium profile

About Gaurav Tiwari

Data last updated:

Gaurav Tiwari is a Director at Sact Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Sact Pharmaceuticals Private Limited reported revenue of ₹30,120 (FY 2021).

DIN 08896778
Primary Designation Director
Industry Chemicals
First Appointment 28 Sep 2020
Oldest Company Age 6 yrs
Largest company Sact Pharmaceuticals Private Limited · ₹30,120 (FY 2021)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Sact Pharmaceuticals Private Limited U24230UP2020PTC135339
Director28 Sep 20202020₹30,120 (FY 2021)Active

Board colleagues of Gaurav Tiwari

NameDINCompanyDesignation
Saurabh Tiwari08896779Sact Pharmaceuticals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Sact Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Gaurav Tiwari

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Gaurav Tiwari

Gaurav Tiwari currently holds 1 directorship: Sact Pharmaceuticals Private Limited (Director, since 28 Sep 2020, revenue ₹30,120 (FY 2021)).

Gaurav Tiwari was first appointed on 28 Sep 2020 as Director at Sact Pharmaceuticals Private Limited.

The current boards of Gaurav Tiwari's companies include Saurabh Tiwari (Sact Pharmaceuticals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available